A second class action has been brought against Jaguar Land Rover over alleged defective diesel filters in its vehicles, and the law firms running the two cases have been given until the end of the month to reach a deal to avoid a court showdown.
A judge has opened the administration of a $300 million settlement in a pelvic mesh class action to a competitive bidding process, shortly after another judge said law firms were not uniquely qualified to distribute class action spoils.
A judge has found the applicant in a dismissed class action against animal health giant Zoetis is liable for the company’s defence costs in the case centering on alleged serious side effects of horse vaccine Equivac.
The Australian supplier of alleged combustible cladding is opposing a class action applicantâs bid for information ahead of settlement talks on the quantity of cladding sold in the country between 2009 and 2019.
A contradictor in two pelvic mesh class actions against Johnson & Johnson has opposed Shine Lawyers recovering $100 million in costs from a $300 million settlement, which a judge has preliminarily found is not fair and reasonable to group members.
A judge has stayed a class action on behalf of 6,000 women allegedly injured by defective pelvic mesh devices after Astora Women’s Health filed for bankruptcy in the United States, but questioned how the company had suddenly come to have no assets.
A class action against Bayer over its allegedly defective Essure contraceptive devices has admonished the drug manufacturerâs bid to shield emails considered privileged in similar US litigation, arguing âthoughts and prayersâ are needed to sustain the claim.
A judge has savaged Shine Lawyers over its failure to present a signed settlement agreement to the court a month after Johnson & Johnson Medical and unit Ethicon agreed to pay $300 million to settle two pelvic mesh class actions, ordering the firm to explain on the record what steps have been taken to finalise the settlement.
The judge overseeing a class action against US medical device maker Boston Scientific is considering appointing a contradictor to look over the $105 million settlement reached in the case, despite seeing no obvious obstacle to approving the deal.
A judge has paused a class action on behalf of 6,000 women allegedly injured by defective pelvic mesh devices pending determination of an application by Astora Health for a stay of the proceedings following its bankruptcy filing.